King patent opposition analysis

The comprehensive analysis of King opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by King

Patent NumberTitleApplicantOpposition DateOpposition Company
Multispecific Antigen-Binding Molecule With Improved Internalization CharacteristicsGENMABJan 9, 2026ELKINGTON AND FIFE
Combination Of A 4-Pyrimidinesulfamide Derivative With An Sglt-2 Inhibitor For The Treatment Of Endothelin Related DiseasesIDORSIA PHARMACEUTICALSJan 8, 2026ELKINGTON AND FIFE
Absorbent ArticleESSITY HYGIENE AND HEALTH AKTIEBOLAGJan 2, 2026THE PROCTER & GAMBLE
Blade Set For A Hair ClipperWAHLJan 2, 2026THE PROCTER & GAMBLE
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKDec 24, 2025POLPHARMA
Thyroid Hormone Receptor Agonists And Uses ThereofFRONTHERA PHARMACEUTICALSDec 19, 2025ELKINGTON AND FIFE
Absorbent CompositesBERRYDec 19, 2025THE PROCTER & GAMBLE
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 18, 2025ADVANZ PHARMA SERVICES UK
High Protein Enteral Tube Feed For Icu PatientsFRESENIUS KABI DEUTSCHLANDDec 16, 2025NESTLE
Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell FunctionF HOFFMANN LA ROCHENov 28, 2025SANDOZ